Clinical Report: Fluorine Tracking Offers Safer Alternative to Drug Metabolism Studies

Overview

A novel analytical workflow utilizing fluorine tracking via ICP-MS presents a non-radioactive alternative for drug metabolism studies. This method allows for sensitive and quantitative metabolite profiling earlier in drug development, reducing exposure to radioactivity for patients and researchers.

Background

Drug metabolism studies have traditionally relied on radioactive labeling, which poses safety risks to both participants and researchers. The introduction of a fluorine tracking method using inductively coupled plasma mass spectrometry (ICP-MS) could revolutionize this field by providing a safer and more efficient approach. Given that fluorine is present in a significant proportion of drugs in development, this technique has the potential to streamline drug development processes.

Data Highlights

No numerical data available in the source material.

Key Findings

• The fluorine tracking method achieves detection limits below 1 ng on-column.
• It provides a uniform, quantitative response across parent drugs and metabolites without the need for radiolabeled compounds.
• The workflow was validated against traditional ¹⁴C radioactivity detection, showing comparable performance.
• This method enables earlier-stage studies, including first-in-human analyses.
• Fluorine tracking could expand study design flexibility in drug metabolism and other applications.

Clinical Implications

The adoption of fluorine tracking in drug metabolism studies could significantly reduce the risks associated with radioactivity. This method allows for earlier and more flexible study designs, potentially accelerating the drug development process.

Conclusion

Fluorine tracking via ICP-MS represents a promising advancement in drug metabolism studies, offering a safer alternative to traditional radioactive methods. Its implementation could enhance the efficiency and safety of drug development.

References

1. Inductively coupled plasma mass spectrometry as a sensitive non-radioactive alternative for quantitative analysis in drug metabolism studies based on fluorine detection | Analytical and Bioanalytical Chemistry | Springer Nature Link, 2026 -- Title
2. The ASCO Post — Fluciclovine PET Imaging Benefits Radiotherapy Treatment Planning Compared With Conventional Imaging in Prostate Cancer KEY POINTS
3. European Radiology — Comparing 68Ga- and 18F-FAPI PET/CT: Capabilities and Limitations
4. the asco post — Dose Escalation of Fluorodeoxyglucose PET–Guided Radiotherapy for Locally Advanced NSCLC
5. The ASCO Post — FAPI PET/CT May Improve Staging in Newly Diagnosed Breast Cancer
6. Guided Sample Pooling in Human Mass Balance Studies: A Recommended Strategic Decision Framework
7. Absorption, Metabolism, Distribution and Excretion (ADME) and Absolute Bioavailability Assessment of Zongertinib in Healthy Male Volunteers
8. Inductively coupled plasma mass spectrometry as a sensitive non-radioactive alternative for quantitative analysis in drug metabolism studies based on fluorine detection | Analytical and Bioanalytical Chemistry | Springer Nature Link